Cineverse Announces Pricing of $3.0 Million Public Offering of Class A Common Stock
Cineverse (Nasdaq: CNVS) priced a public offering of 1,500,000 Class A shares at $2.00 per share, with a 30-day underwriter option for up to 225,000 additional shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Cineverse (Nasdaq: CNVS) priced a public offering of 1,500,000 Class A shares at $2.00 per share, with a 30-day underwriter option for up to 225,000 additional shares. Gross proceeds are expected to be approximately $3.0 million, before fees and expenses.
The offering is expected to close on February 17, 2026, subject to customary closing conditions. Cineverse Chairman and CEO Chris McGurk and other management participated in the offering. Benchmark Company is sole underwriter; the sale uses a previously effective Form S-3 shelf registration.
Positive
- Gross proceeds of approximately $3.0 million
- Management participation by Chairman and CEO Chris McGurk
- Underwriter option for up to 225,000 additional shares provides execution flexibility
Negative
- Share dilution from issuance of 1,500,000 shares to existing shareholders
- Net proceeds reduced by underwriting discounts, commissions and offering expenses
- Close subject to customary conditions; offering not guaranteed to close on Feb 17, 2026
Details
News Market Reaction – CNVS
On Feb 13, the first trading day after this news, CNVS closed 20.19% above the previous close.
Data tracked by StockTitan Argus for the Feb 13 session.
Key Figures
- Shares offered
- 1,500,000 shares
- Class A common stock in public offering
- Offering price
- $2.00 per share
- Public offering price for Class A common stock
- Over-allotment shares
- 225,000 shares
- 30-day underwriter option for additional shares
- Gross proceeds
- $3.0 million
- Expected gross proceeds before expenses, excluding option exercise
- Option period
- 30 days
- Underwriter option to purchase additional shares
- Form S-3 file number
- 333-273098
- Previously effective shelf registration statement cited for this offering
- S-3 effective date
- January 25, 2024
- Date Form S-3 registration statement became effective
- Expected closing date
- February 17, 2026
- Target closing date for the offering, subject to conditions
Historical Context
-
Announced proposed underwritten public offering with 15% over-allotment option.
-
Agreed to acquire IndiCue using cash, stock, and 9% convertible notes.
-
Scheduled Q3 FY2026 results and conference call for February 17, 2026.
-
Launched Matchpoint Creative Labs targeting high-margin AI-driven ad services.
-
Announced digital and upcoming physical releases for Silent Night, Deadly Night.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
public offering financial
underwriter financial
shelf registration statement regulatory
form s-3 regulatory
prospectus supplement regulatory
registration statement regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Benchmark Company, LLC is acting as the sole underwriter for the proposed offering.
A shelf registration statement on Form S-3 (File No. 333-273098) relating to the shares was previously filed with the Securities and Exchange Commission (the "SEC") and became effective on January 25, 2024. The offering will be made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering has been filed with the SEC and is available on the SEC's website at www.SEC.gov. A final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and available on the SEC's website at www.SEC.gov. A copy of the final prospectus supplement and the accompanying prospectus, when available, may be obtained by contacting: The Benchmark Company, LLC, 150 East 58th Street, 17th Floor,
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Cineverse
Cineverse (Nasdaq: CNVS) is an entertainment technology company and studio. Fiercely innovative and independent, Cineverse develops and invests in technology and content that drives the future of the industry. Core to its business is Matchpoint® – a growing tech ecosystem powered by AI and designed to prepare, distribute, monetize, and continuously improve content across any platform. Matchpoint helps studios large and small operate at scale and improve performance and efficiency in an increasingly fragmented distribution environment. Additionally, Cineverse distributes more than 71,000 premium films, series, and podcasts, across theatrical, home entertainment, and streaming; operates dozens of digital properties that super serve passionate fandoms around the world; and works with leading brands to connect them with audiences they value. From award-winning technology to the highest-grossing unrated film in
Forward-Looking Statements
Investors and readers are cautioned that certain statements contained in this document, as well as some statements in periodic press releases and some oral statements of Cineverse officials during presentations about Cineverse, along with Cineverse's filings with the Securities and Exchange Commission, including Cineverse's registration statements, quarterly reports on Form 10-Q and annual report on Form 10-K, are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act''). Forward-looking statements include statements that are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "expects," "anticipates,'' "intends,'' "plans,'' "could," "might," "believes,'' "seeks," "estimates'' or similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings, or growth rates), ongoing business strategies or prospects, and possible future actions, which may be provided by Cineverse's management, are also forward-looking statements as defined by the Act. Forward-looking statements are based on current expectations and projections about future events and are subject to various risks, uncertainties, and assumptions about Cineverse, its technology, economic and market factors, and the industries in which Cineverse does business, among other things. These statements are not guarantees of future performance, and Cineverse undertakes no specific obligation or intention to update these statements after the date of this release.
For additional information, please contact:
For Media
The Lippin Group for Cineverse
cineverse@lippingroup.com
At Cineverse
Julie Milstead
investorrelations@cineverse.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cineverse-announces-pricing-of-3-0-million-public-offering-of-class-a-common-stock-302687220.html
SOURCE Cineverse Corp.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.